ProMIS Neurosciences Inc (PMN)-医療機器分野:企業M&A・提携分析

◆英語タイトル:ProMIS Neurosciences Inc (PMN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010916
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd. is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, which helps in predicting new disease specific epitopes on the molecular surface of misfolded proteins. Based on ProMIS technology, the company is developing antibody therapeutics and diagnostics targeting cancer and amyotrophic lateral sclerosis (ALS). The company Epitope Protection and AMFIA has two therapeutic programs: Alzheimer’s therapeutic tau program and ALS therapeutic TD4P3 program. The company’s products and services include therapeutics, diagnostic kits, diagnostic services, and reagents. ProMIS is headquartered in Toronto, Ontario, Canada.

ProMIS Neurosciences Inc (PMN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
ProMIS Neurosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
ProMIS Neurosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
ProMIS Neurosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
ProMIS Neurosciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
ProMIS Neurosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
ProMIS Neurosciences Inc, Medical Equipment, Deal Details 11
Partnerships 11
Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 11
Amorfix Life Sciences Enters Into Co-Development Agreement With Trellis Bioscience 13
Amorfix Life Sciences Enters Into Agreement With Pharma Company For Alzheimer’s Disease Diagnostic 14
Amorfix Life Sciences Enters Into Co-Development Agreement With QPS Holdings 15
Equity Offering 16
ProMIS Neurosciences Raises USD1 Million in Second Tranche of Private Placement of Units 16
ProMIS Neurosciences Raises USD0.4 Million in Private Placement of Units 18
ProMIS Neurosciences Raises USD0.8 Million in Private Placement of Units 20
ProMIS Neurosciences Raises USD0.3 Million in Second and Final Tranche of Private Placement of Shares 21
ProMIS Neurosciences Raises USD0.5 Million in First Tranche of Private Placement of Shares 22
ProMIS Neurosciences to Raise Funds Through Rights Offering of Shares 23
Amorfix Life Sciences Completes Third Tranche Of Private Placement Of Shares And Warrants For US$1 Million 24
Amorfix Life Sciences Completes Private Placement Of Securities For US$0.4 Million 25
Amorfix Life Sciences Raises USD0.25 Million In a Private Placement Of Shares 26
Amorfix Life Sciences Completes Private Placement Of Units For US$0.5 Million 27
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Shares For US$0.2 Million 28
Amorfix Life Sciences Completes First Tranche Of Private Placement Of Units For US$0.5 Million 29
Amorfix Life Sciences Completes Second And Final Tranche Of Private Placement Of Units For US$0.3 Million 30
Amorfix Life Sciences Completes Private Placement Of Units For US$0.2 Million 31
Amorfix Life Sciences Completes Private Placement Of Units For US$1 Million 32
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Units For US$0.08 Million 33
Amorfix Life Sciences Completes Private Placement Of US$0.51 Million 35
ProMIS Neurosciences Inc – Key Competitors 37
ProMIS Neurosciences Inc – Key Employees 38
ProMIS Neurosciences Inc – Locations And Subsidiaries 39
Head Office 39
Recent Developments 40
Financial Announcements 40
Nov 13, 2017: ProMIS Neurosciences Announces Third Quarter 2017 Results 40
Aug 11, 2017: ProMIS Neurosciences Announces Second Quarter 2017 Results 42
Jul 10, 2017: ProMIS Neurosciences Provides Second Quarter Update for 2017 44
May 09, 2017: ProMIS Neurosciences Announces Q1 2017 Quarterly Results 45
Mar 30, 2017: ProMIS Neurosciences announces overview of first quarter 2017 progress and outlook for near term value creation 46
Mar 15, 2017: ProMIS Neurosciences Announces Fiscal 2016 Annual Results 47
Nov 02, 2016: ProMIS Neurosciences Announces Third Quarter 2016 Results 49
Aug 12, 2016: ProMIS Neurosciences Announces Second Quarter 2016 Results 51
May 11, 2016: ProMIS Neurosciences announces first quarter 2016 results 53
Mar 23, 2016: ProMIS Neurosciences announces FY2015 year end results 54
Corporate Communications 57
Jun 06, 2017: ProMIS Neurosciences Appoints William C. Mobley to Scientific Advisory Board 57
Mar 22, 2017: ProMIS Neurosciences Announces Appointment of Daniel Geffken as Chief Financial Officer 58
Mar 02, 2017: ProMIS Neurosciences announces appointment of Anthony Giovinazzo to its Board of Directors 59
Oct 18, 2016: ProMIS Neurosciences announces appointment of Dr. Richard Gregory to its Board of Directors 60
Jul 21, 2016: ProMIS Neurosciences Announces Appointment of Dr. Johanne Kaplan as Chief Development Officer 61
Jan 26, 2016: ProMIS Neurosciences announces formation of prestigious Scientific Advisory and Business Advisory Boards 62
Appendix 63
Methodology 63
About GlobalData 63
Contact Us 63
Disclaimer 63

List of Tables
ProMIS Neurosciences Inc, Medical Equipment, Key Facts, 2016 2
ProMIS Neurosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
ProMIS Neurosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
ProMIS Neurosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
ProMIS Neurosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
ProMIS Neurosciences Inc, Deals By Market, 2011 to YTD 2017 9
ProMIS Neurosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 11
Amorfix Life Sciences Enters Into Co-Development Agreement With Trellis Bioscience 13
Amorfix Life Sciences Enters Into Agreement With Pharma Company For Alzheimer's Disease Diagnostic 14
Amorfix Life Sciences Enters Into Co-Development Agreement With QPS Holdings 15
ProMIS Neurosciences Raises USD1 Million in Second Tranche of Private Placement of Units 16
ProMIS Neurosciences Raises USD0.4 Million in Private Placement of Units 18
ProMIS Neurosciences Raises USD0.8 Million in Private Placement of Units 20
ProMIS Neurosciences Raises USD0.3 Million in Second and Final Tranche of Private Placement of Shares 21
ProMIS Neurosciences Raises USD0.5 Million in First Tranche of Private Placement of Shares 22
ProMIS Neurosciences to Raise Funds Through Rights Offering of Shares 23
Amorfix Life Sciences Completes Third Tranche Of Private Placement Of Shares And Warrants For US$1 Million 24
Amorfix Life Sciences Completes Private Placement Of Securities For US$0.4 Million 25
Amorfix Life Sciences Raises USD0.25 Million In a Private Placement Of Shares 26
Amorfix Life Sciences Completes Private Placement Of Units For US$0.5 Million 27
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Shares For US$0.2 Million 28
Amorfix Life Sciences Completes First Tranche Of Private Placement Of Units For US$0.5 Million 29
Amorfix Life Sciences Completes Second And Final Tranche Of Private Placement Of Units For US$0.3 Million 30
Amorfix Life Sciences Completes Private Placement Of Units For US$0.2 Million 31
Amorfix Life Sciences Completes Private Placement Of Units For US$1 Million 32
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Units For US$0.08 Million 33
Amorfix Life Sciences Completes Private Placement Of US$0.51 Million 35
ProMIS Neurosciences Inc, Key Competitors 37
ProMIS Neurosciences Inc, Key Employees 38

★海外企業調査レポート[ProMIS Neurosciences Inc (PMN)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Enmax Corporation:発電所・企業SWOT分析
    Enmax Corporation – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Marksmen Energy Inc (MAH):企業の財務・戦略的SWOT分析
    Summary Marksmen Energy Inc (Marksmen Energy), formerly Marksmen Resources Ltd, is an oil and gas exploration and development company that explores and develops light oil assets in Ohio. The company acquires, explores, operates, manages, produces and develops oil and gas properties in Western Canada …
  • BPH Energy Ltd (BPH):企業の財務・戦略的SWOT分析
    BPH Energy Ltd (BPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mechel:企業の戦略・SWOT・財務情報
    Mechel - Strategy, SWOT and Corporate Finance Report Summary Mechel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Cellectar Biosciences Inc (CLRB):製薬・医療:M&Aディール及び事業提携情報
    Summary Cellectar Biosciences Inc (Cellectar) develops phospholipid drug conjugates (PDCs) for the treatment and diagnosis of cancer. Its lead product, CLR 131, is a small-molecule radiotherapeutic PDC, being developed for the treatment of relapse or refractory multiple myeloma. Cellectar’s other pr …
  • Challenge Group Holdings PTE. LTD.:企業の戦略・SWOT・財務情報
    Challenge Group Holdings PTE. LTD. - Strategy, SWOT and Corporate Finance Report Summary Challenge Group Holdings PTE. LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • PSE Kinsale Energy Ltd:企業の戦略的SWOT分析
    PSE Kinsale Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Mediware Information Systems Inc-製薬・医療分野:企業M&A・提携分析
    Summary Mediware Information Systems Inc (Mediware) is a healthcare solutions company that designs, develops and commercializes specialized healthcare software. It provides software to healthcare and human service providers and payers. The company’s portfolio of solutions are equipped in blood banks …
  • TransMontaigne Partners LP (TLP):石油・ガス:M&Aディール及び事業提携情報
    Summary TransMontaigne Partners LP (TLP), a subsidiary of TransMontaigne GP LLC is an energy infrastructure service provider that offers integrated terminaling, transportation, and storage services. The company distributes and transports crude oil, chemicals, petroleum products, fertilizers, and oth …
  • McCarthy Building Companies Inc:企業の戦略・SWOT・財務情報
    McCarthy Building Companies Inc - Strategy, SWOT and Corporate Finance Report Summary McCarthy Building Companies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Apollo Commercial Real Estate Finance, Inc.:企業のM&A・事業提携・投資動向
    Apollo Commercial Real Estate Finance, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Apollo Commercial Real Estate Finance, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Credicorp Ltd (BAP):企業の財務・戦略的SWOT分析
    Credicorp Ltd (BAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Agilvax Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Agilvax Inc (Agilvax) is a drug company that discovers and develops vaccines against infectious diseases and immunotherapies to treat cancer. The company develops products based on a proprietary virus-like particle platform technology. It develops immunotherapies to treat breast cancer, lung …
  • W&T Offshore Inc (WTI):石油・ガス:M&Aディール及び事業提携情報
    Summary W&T Offshore Inc (W&T Offshore) is an independent oil and natural gas company. It carries out acquisition, exploitation, development and exploration of oil and natural gas assets both onshore and offshore in the Gulf of Mexico. The company acquires rights to explore and develop new prospects …
  • CACI International Inc. (CACI):企業の戦略的SWOT分析
    CACI International Inc. (CACI) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Hamamatsu Photonics KK (6965):企業の財務・戦略的SWOT分析
    Hamamatsu Photonics KK (6965) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • PharmaEngine Inc (4162):製薬・医療:M&Aディール及び事業提携情報
    Summary PharmaEngine Inc (PharmaEngine) is a biopharmaceutical company that discovers and develops cancer treatment drugs and related medicinal products. The company develops drugs for the treatment of cancer and Asian prevalent diseases. Its products include Onivyde a liposome encapsulation of irin …
  • H.I.S. Co., Ltd.:企業の戦略・SWOT・財務情報
    H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Polycom Inc:企業の戦略的SWOT分析
    Polycom Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • New Flyer Industries Inc.:企業の戦略・SWOT・財務情報
    New Flyer Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary New Flyer Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆